A comprehensive view of DaVita Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

DaVita reports Q2 net income down at US$224.8M from US$293.8M a year ago, with total revenue up at US$2.92B from US$2.91B a year ago; DaVita provided 7,269,160 dialysis treatment in Q2, up 0.9% from Q1 2022

US Supreme Court rejects DaVita’s claim that Ohio hospital's employee health plan discriminated against end-stage renal disease patients to switch them to Medicare; DaVita says ruling could result in private health plans limiting dialysis coverage

DaVita reports Q1 net income down at US$162.1M from US$237.4M a year ago, with consolidated revenue at US$2.8B, flat from a year ago; results impacted by COVID-19 volume pressures from excess patient mortality, higher missed treatments

CDC COVID-19 vaccination program with DaVita, Fresenius, others shows Hispanic, Black, Asian patients with end-stage kidney disease more likely to get vaccination at dialysis center; over 500,000 ESKD patients in US receive dialysis care

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count